COSM - CIK 0001474167
Cosmos Health Inc. trades as COSM. In its fiscal 2025 annual report the company posted revenue of $65.27M, up 19.9% from the prior year and net income of -$19.14M. This page tracks Cosmos Health Inc. through 600 SEC filings, with financial statements and metrics updated as new reports are filed.
Over the last 9 fiscal years Cosmos Health Inc.'s revenue grew from $6.76M to $65.27M, a compound annual growth rate of 28.7%. Net profit margin compressed from -8.9% to -29.3% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| PRE 14A | - | 2026-05-22 |
| Major company event | 8-K | 2026-05-22 |
| Quarterly report | 10-Q | 2026-05-20 |
| NT 10-Q | - | 2026-05-15 |
| RW | - | 2026-05-11 |
| SCHEDULE 13G/A | - | 2026-04-24 |
| S-3/A | - | 2026-04-24 |
| Major company event | 8-K | 2026-04-16 |
The largest companies sharing Cosmos Health Inc.'s SEC industry classification (wholesale-drugs, proprietaries & druggists' sundries).
Cosmos Health Inc. reported revenue of $65.27M for fiscal year 2025, an increase of 19.9% year over year.
In its latest fiscal year Cosmos Health Inc. reported a net loss of $19.14M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.